Abstract
Introduction
Pancreatic metastasis from several malignancies are increasingly encountered in clinical practice, and the usefulness of surgical resection has been suggested for certain neoplasms. Isolated pancreatic metastasis from malignant melanoma is a rare occurrence, and the role of surgery as an adjunct to systemic therapy for melanoma metastatic to a solitary or multiple sites is still debated.
Case Report
We report a patient with melanoma of unknown primary site metastatic simultaneously to the lung and pancreas 3 years after axillary lymph node dissection. Distal pancreatectomy with splenectomy and video thoracoscopic assisted resection of pulmonary metastasis were performed. The postoperative course was uneventful, but 6 months after surgery, the patient experienced single pulmonary recurrence. During chemotherapy with different drugs, pulmonary lesion remained stable for 1 year, and no abdominal recurrence occurred. After then, the size of the lesion progressively increased and a second metastasis occurred in the lung. Five months later, brain metastases occurred, and the patients died 24 months after surgery. Sixteen pancreatic resections for metastatic malignant melanoma, reported with adequate clinical details, were also retrieved from the literature.
Conclusion
In spite of the very limited experience, it appears that surgical resection is only a palliative procedure, because long-term survival is a rare event. However, considering the lack of effective systemic therapy, surgery may be considered as a part of an aggressive multidisciplinary approach in selected cases with malignant melanoma metastatic to single or multiple visceral sites.
References
Reddy S, Wolfgang CI. The role of surgery in the management of isolated metastases to the pancreas. Lancet Oncol. 2009;10:287–93. doi:10.1016/S1470-2045(09)70065-8.
McLoughlin JM, Zager JS, Sondak VK, Berk LB. Treatment options for limited or symptomatic metastatic melanoma. Cancer Control. 2008;15:239–47.
Sweeney AD, Wu MF, Hilsenbeck SG, Brunicardi FC, Fisher WE. Value of pancreatic resection for cancer metastatic to the pancreas. J Surg Res. 2009;156:189–98. doi:10.1016/j.jss.2009.01.017.
Wood TF, DiFronzo A, Rose M, Haigh PI, Stern SL, Wanek L, et al. Does complete resection of melanoma metastatic to solid intra-abdominal organs improve survival? Ann Surg Oncol. 2001;8:658–62. doi:10.1007/s10434-001-0658-4.
Gutman H, Hess KR, Kokotsakis JA, Ross MI, Guinee VF, Balch CM. Surgery for abdominal metastases of cutaneous melanoma. World J Surg. 2001;25:750–8. doi:10.1007/s00268-001-0027-2.
Showalter SL, Hager E, Yeo CJ. Metastatic disease to the pancreas and spleen. Semin Oncol. 2008;35:160–71. doi:10.1053/j.seminoncol.2007.12.008.
Reddy S, Edil BH, Cameron JL, Pawlik TM, Herman JM, Gilson MM, et al. Pancreatic resection of isolated metastases from nonpancreatic primary cancers. Ann Surg Oncol. 2008;15:3199–206. doi:10.1245/s10434-008-0140-7.
Sobin LH, Wittekind C. AJCC: TNM classification of malignant tumors. 6th ed. New York: John Wiley and Sons, Inc.; 2002.
Strobel O, Hackert T, Hartwig W, Bergmann F, Hinz U, Wente MN, et al. Survival data justifies resection for pancreatic metastases. Ann Surg Oncol. 2009;16:3340–9. doi:10.1245/s10434-009-0682-3.
Masetti M, Zanini N, Martuzzi F, Fabbri C, Mastrangelo L, Landolfo G, et al. Analysis of prognostic factors in metastatic tumors of the pancreas. A single-center experience and review of the literature. Pancreas. 2010;39:135–43. doi:10.1097/MPA.0b013e3181bae9b3.
Wong JH, Euhus DM, Morton DL. Surgical resection for metastatic melanoma to the lung. Arch Surg. 1988;123:1091–5.
Tafra L, Dale PS, Wanek LA, Romming KP, Morton DL. Resection and adjuvant immunotheraphy for melanoma metastatic to the lung and thorax. J Thorac Cardiovasc. 1991;110:119–28. doi:10.1016/S0022-5223(05)80017-0. discussion 129.
Harrison LE, Merchant N, Cohen AM, Brennan MF. Pancreaticoduodenectomy for non-periampullary primary tumors. Am J Surg. 1997;174:394–5. doi:10.1016/S0002-9610(97)00121-9.
Hiotis SP, Klimstra DS, Conlon KC, Brennan MF. Results after pancreatic resection for metastatic lesions. Ann Surg Oncol. 2002;9:675–9. doi:10.1007/BF02574484.
Roland CF, Van Heerden JA. Nonpancreatic primary tumors with metastasis to the pancreas. Surg Gynecol Obstet. 1989;168:345–7.
Pingpank JF, Hoffman JP, Sigurdson ER, Ross E, Sasson AR, Eisenberg BL. Pancreatic resection for locally advanced primary and metastatic nonpancreatic neoplasms. Am Surg. 2002;68:337–41.
Lasser Ph, Hardy Ch, Cheynel C, Bognel C. Pancreaticoduodenectomy for pancreatic metastasis from malignant melanoma. J Chir. 1990;127:494–5.
Brodish RJ, McFadden DW. The pancreas as the solitary site of metastasis from melanoma. Pancreas. 1993;8:276–8. doi:10.1097/00006676-199303000-00023.
Medina-Franco H, Halpern NB, Aldrete JS. Pancreaticoduodenectomy for metastatic tumors to the periampullary region. J Gastrointest Surg. 1999;3:119–22. doi:10.1016/S1091-255X(99)80019-5.
Camp R, Lind DS, Hemming AW. Combined liver and pancreas resection with biochemotherapy for metastatic ocular melanoma. J Hepatobiliary Pancreat Surg. 2002;9:519–21. doi:10.1007/s005340200066.
Nikfarjam M, Evans P, Christophi C. Pancreatic resection for metastatic melanoma. HPB. 2003;5:174–9.
Carboni F, Graziano F, Lonardo MT, Lepiane P, Santoro R, Lorusso R, et al. Pancreaticoduodenectomy for pancreatic metastatic melanoma. J Exp Clin Cancer Res. 2004;23:539–43.
Crippa S, Angelini C, Mussi C, Bonardi C, Romano F, Sartori P, et al. Surgical treatment of metastatic tumors to the pancreas: a single center experience and review of the literature. World J Surg. 2006;30:1536–42. doi:10.1007/s00268-005-0464-4.
Belagyi T, Zsoldos P, Makay R, Issekutz A, Olah A. Multiorgan resection (including the pancreas) for metastatis of cutaneous malignant melanoma. JOP J Pancreas online. 2006;7:234–40.
Edit S, Jergas M, Schmidt R, Siedek M. Metastasis to the pancreas – an indication for pancreatic resection? Langenbecks Arch Surg. 2007;392:539–42. doi:10.1007/s00423-007-0148-7.
Vagefi PA, Stangenberg L, Krings G, Forcione DG, Wargo JA (2009). Ocular melanoma metastatic to the pancreas after 28-year disease-free interval. Surgery (Epub ahead of print).
Atallah E, Flaherty L. Treatment of metastatic malignant melanoma. Curr Treat Op Oncol. 2005;6:185–93. doi:10.1007/s11864-005-0002-5.
Guillot B, Khamari A, Cupissol D, Delanunay M, Bedane C, Dreno B, et al. Temozolomide associated with PEG- interferon in patients with metastatic melanoma: a multicenter prospective phase I/II study. Melanoma Res. 2008;18:141–6. doi:10.1097/CMR.0b013e3282f6309c.
O’Day S, Gonzalez R, Lawson D, Weber R, Hutchins L, Anderson C, et al. Phase II, randomized, controlled, double-blinded trial of weekly elesclomol plus paclitaxel versus paclitaxel alone for stage IV metastatic melanoma. J Clin Oncol. 2009;27:5452–8. doi:10.1200/JCO.2008.17.1579.
Yang AS, Chapman PB. The history and future of chemotherapy for melanoma. Hematol Oncol Clin N Am. 2009;23:583–97. doi:10.1016/j.hoc.2009.03.006.
Acknowledgments
We thank very much Miss Tania Lazzarin for help in the preparation of the manuscript.
Conflict of interest
The authors declare that they have no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sperti, C., Polizzi, M.L., Beltrame, V. et al. Pancreatic Resection for Metastatic Melanoma. Case Report and Review of the Literature. J Gastrointest Canc 42, 302–306 (2011). https://doi.org/10.1007/s12029-010-9169-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12029-010-9169-5